Let’s Work Together

Plaque Psoriasis

Plaque psoriasis

The main purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of investigative medication BMS-986165 in adolescent participants aged 12 to <18 years who have been clinically diagnosed with moderate to severe plaque psoriasis.

Inclusion criteria

To take part in this study, participants need to be:

  • 12-17 years old
  • Lives in Victoria

Location of Study

Contact details

Why do I want to participate?

To identify the efficacy of the drug to better the life quality of adolescents who have moderate to severe plaque psoriasis.